Abstract:Background: Diagnosis of primary diffuse large B-cell lymphoma of the central nervous system (PCNSL) is challenging and often delayed. MRI imaging, CSF cytology and flow cytometry have a low sensitivity and even brain biopsies can be misleading. We report three cases of PCNSL with various clinical presentation and radiological findings where the diagnosis was suggested by novel CSF biomarkers and subsequently confirmed by brain biopsy or autopsy. Case presentations: The first case is a 79-year-old man with severe neurocognitive dysfunction and static ataxia evolving over 5 months. Brain MRI revealed a nodular ventriculitis. An open brain biopsy was inconclusive. The second case is a 60-year-old woman with progressive sensory symptoms in all four limbs, evolving over 1 year. Brain and spinal MRI revealed asymmetric T2 hyperintensities of the corpus callosum, corona radiata and corticospinal tracts. The third case is a 72-year-old man recently diagnosed with primary vitreoretinal lymphoma of the right eye. A follow-up brain MRI performed 4 months after symptom onset revealed a T2 hyperintense fronto-sagittal lesion, with gadolinium uptake and perilesional edema. In all three cases, CSF flow cytometry and cytology were negative. Mutation analysis on the CSF (either by digital PCR or by next generation sequencing) identified the MYD88 L265P hotspot mutation in all three cases. A B-cell clonality study, performed in case 1 and 2, identified a monoclonal rearrangement of the immunoglobulin light chain lambda (IGL) and kappa (IGK) gene. CSF CXCL-13 and IL-10 levels were high in all three cases, and IL-10/IL-6 ratio was high in two. Diagnosis of PCNSL was later confirmed by autopsy in case 1, and by brain biopsy in case 2 and 3. Conclusions: Taken together, 5 CSF biomarkers (IL-10, IL-10/IL-6 ratio, CXCL13, MYD88 mutation and monoclonal IG gene rearrangements) were strongly indicative of a PCNSL. Using innovative CSF biomarkers can be sensitive and complementary to traditional CSF analysis and brain biopsy in the diagnosis of PCNSL, potentially allowing for earlier diagnosis and treatment.

Could Cerebral Inflammatory Lesions be the Cellular Origin of Primary Central Nervous System Lymphoma?

Primary central nervous system lymphoma mimicking recurrent depressive disorder: A case report.

Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.

Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) - Case reports and literature review

Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis

Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers

Cell-Block cytology in diagnosis of primary central nervous system lymphoma

Role of Cerebrospinal Fluid Cytology in Diagnosis of Primary Central Nervous System Lymphoma

Primary central nervous system lymphoma: a series report and literature review

A Case Report and Review of Primary Central Nervous System Lymphoma Preceded by Multifocal White Matter Lesions and Brain Atrophy

Primary Central Nervous System Lymphoma: From Clinical Presentation to Diagnosis

Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases

A Case of Primary Central Nervous System Lymphoma Mimic Neuromyelitis Optica

Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features

Clinical features analysis on primary central nervous system lymphoma

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas

Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment

Primary Intravascular Malignant Lymphomatosis Angiotropic BCell Lymphomas in Central Nervous System:A Case Report and Literature Review

A Retrospective Study of 40 Cases of Pathologically Established Primary Central Nervous System Lymphoma

Advances in relevant prognostic factors of primary central nervous system lymphoma

The Characteristics of Cerebrospinal Fluid Anaplastic Large Cells in a Patient with Primary Leptomeningeal Anaplastic Large Cell Lymphoma.